Tamoxifen citrate Prescribing at ROTHSCHILD HOUSE GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
604
Total Quantity
23.1K
NHS Cost
£2.1K
vs National Avg
+633.4%
ROTHSCHILD HOUSE GROUP prescribed 604 items of Tamoxifen citrate over the last 12 months at a cost of £2,121 to the NHS. This is 633.4% above the national average prescribing rate. Tamoxifen citrate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
51
Jul 2026
59
Jul 2026
55
Jul 2026
51
Jul 2026
51
Jul 2026
58
Jul 2026
49
Jul 2026
51
Jul 2026
49
Jul 2026
38
Jul 2026
50
Jul 2026
42
Prescribing Details
| Total Items | 604 |
|---|---|
| Total Quantity | 23,081 |
| Total NHS Cost | £2,121 |
| Presentations | 2 different forms |
| vs National Average | +633.4% |
Tamoxifen citrate Prescribing Comparison
| This practice | 604 items |
|---|---|
| National average per practice | 82 items |
| Difference | +633.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.